SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed?
Autor: | Corrado Lisi, Alessandra Roselli, Marco Bonifazi, Maria Teresa Cappellini, Michele Cillis, Nicola Mochi, Serafina Valente, Giulia Elena Mandoli, Massimo Capitani, Arnel Hajdarevic, Flavio D'Ascenzi, Veronica Mochi, Silvia Giovani, Federico Alvino, Rosa Anna Colloca, Marta Focardi, Matteo Cameli, Federica Frascaro, Luna Cavigli |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
medicine.medical_specialty Adolescent Heart Diseases Population Physical Therapy Sports Therapy and Rehabilitation Competitive athletes Physical examination Pericardial effusion Asymptomatic Pericarditis Internal medicine medicine Humans Orthopedics and Sports Medicine Prospective Studies education education.field_of_study medicine.diagnostic_test biology SARS-CoV-2 Athletes business.industry Incidence (epidemiology) COVID-19 General Medicine athletes child health sports medicine.disease biology.organism_classification Return to Sport medicine.symptom business |
Zdroj: | British Journal of Sports Medicine. 56:264-270 |
ISSN: | 1473-0480 0306-3674 |
Popis: | BackgroundSARS-CoV-2 infection might be associated with cardiac complications in low-risk populations, such as in competitive athletes. However, data obtained in adults cannot be directly transferred to preadolescents and adolescents who are less susceptible to adverse clinical outcomes and are often asymptomatic.ObjectivesWe conducted this prospective multicentre study to describe the incidence of cardiovascular complications following SARS-CoV-2 infection in a large cohort of junior athletes and to examine the effectiveness of a screening protocol for a safe return to play.MethodsJunior competitive athletes suffering from asymptomatic or mildly symptomatic SARS-CoV-2 infection underwent cardiac screening, including physical examination, 12-lead resting ECG, echocardiogram and exercise ECG testing. Further investigations were performed in cases of abnormal findings.ResultsA total of 571 competitive junior athletes (14.3±2.5 years) were evaluated. About half of the population (50.3%) was mildly symptomatic during SARS-CoV-2 infection, and the average duration of symptoms was 4±1 days. Pericardial involvement was found in 3.2% of junior athletes: small pericardial effusion (2.6%), moderate pericardial effusion (0.2%) and pericarditis (0.4%). No relevant arrhythmias or myocardial inflammation was found in subjects with pericardial involvement. Athletes with pericarditis or moderate pericardial effusion were temporarily disqualified, and a gradual return to play was achieved after complete clinical resolution.ConclusionsThe prevalence of cardiac involvement was low in junior athletes after asymptomatic or mild SARS-CoV-2 infection. A screening strategy primarily driven by cardiac symptoms should detect cardiac involvement from SARS-CoV-2 infection in most junior athletes. Systematic echocardiographic screening is not recommended in junior athletes. |
Databáze: | OpenAIRE |
Externí odkaz: |